Publication | Closed Access

I4, a new synthetic sulfonylurea compound, inhibits the action of TXA2 in vivo and in vitro on platelets and aorta vascular smooth muscle

ThrombosisMolecular PharmacologyBiochemistryBlood PlateletMedicineVascular PharmacologyCardiovascular PharmacologyVascular BiologyPharmacotherapyVascular Smooth MusclePharmacologyPlatelet AntagonistAtherosclerosisDrug Discovery